Huma Rasheed
Impact in
-
- Antibiotic Use and Resistance
-
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Pharmaceutical Quality and Counterfeiting 4
-
- Pharmaceutical Economics and Policy 6
- Co-authors
- Ulrike Holzgrabe (2 shared papers)Zaheer‐Ud‐Din Babar (4 shared papers)Mamoona Chaudhry (2 shared papers)Saba Shamim (1 shared paper)Mohammad Saleem (1 shared paper)Muhammad Ijaz (2 shared papers)Waqas Ahmed (1 shared paper)Sitaram Khadka (1 shared paper)
- Journals
- Frontiers in Pharmacology (3 papers)Journal of Pharmaceutical Policy and Practice (1 paper)Frontiers in Public Health (1 paper)Advanced Powder Technology (1 paper)Advances in Pharmacological and Pharmaceutical Sciences (1 paper)
- Partner nations
- PakistanUnited KingdomUnited States
In The Last Decade
Huma Rasheed
15 papers receiving 93 citations
Peers
Comparison fields: 5 of 61
- Applied Microbiology and Biotechnology 14
- Geriatrics and Gerontology 10
- Public Health, Environmental and Occupational Health 38
- Economics and Econometrics 33
- Family Practice 2
Countries citing papers authored by Huma Rasheed
This map shows the geographic impact of Huma Rasheed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huma Rasheed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huma Rasheed more than expected).
Fields of papers citing papers by Huma Rasheed
This network shows the impact of papers produced by Huma Rasheed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huma Rasheed. The network helps show where Huma Rasheed may publish in the future.
Co-authors
The 25 scholars most cited alongside Huma Rasheed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 19 | |
| 2 | 2018 | 17 | |
| 3 | 2021 | 11 | |
| 4 | 2021 | 7 | |
| 5 | 2021 | 7 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 6 | |
| 8 | 2019 | 5 | |
| 9 | 2024 | 4 | |
| 10 | 2021 | 3 | |
| 11 | Formulation of Phaseolus vulgaris L. cream and its characterization. | 2020 | 3 |
| 12 | 2013 | 2 | |
| 13 | 2021 | 1 | |
| 14 | 2021 | 1 | |
| 15 | 2021 | 1 | |
| 16 | 2025 | 0 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 |
About Huma Rasheed
Huma Rasheed is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics, Food Science, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 19 papers that have together received 94 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (6 papers), Pharmaceutical Quality and Counterfeiting (4 papers), Antibiotic Use and Resistance (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Pharmaceutical studies and practices (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers) and Pneumonia and Respiratory Infections (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (14 citations), Geriatrics and Gerontology (10 citations), Public Health, Environmental and Occupational Health (38 citations), Economics and Econometrics (33 citations) and Family Practice (2 citations). Huma Rasheed has collaborated with scholars based in Pakistan, United Kingdom and United States. Frequent co-authors include Ulrike Holzgrabe, Zaheer‐Ud‐Din Babar, Mamoona Chaudhry, Saba Shamim, Mohammad Saleem, Muhammad Ijaz, Waqas Ahmed, Sitaram Khadka, Muhammad Usman and Amna Saeed. Their work appears in journals such as Frontiers in Pharmacology, Journal of Pharmaceutical Policy and Practice, Frontiers in Public Health, Advanced Powder Technology and Advances in Pharmacological and Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.